Cetera Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,172
Closed -$373K 6
2017
Q2
$373K Sell
2,172
-484
-18% -$78.7K 0.47% 71
2017
Q1
$436K Sell
2,656
-1,642
-38% -$273K 0.5% 76
2016
Q4
$628K Sell
4,298
-794
-16% -$119K 0.47% 79
2016
Q3
$849K Sell
5,092
-690
-12% -$117K 0.55% 67
2016
Q2
$880K Sell
5,782
-672
-10% -$104K 0.52% 73
2016
Q1
$964K Sell
6,454
-603
-9% -$89.6K 0.5% 73
2015
Q4
$1.14M Buy
+7,057
New +$1.11M 0.46% 86

Other funds holding AMGN

Cetera Investment Management's AMGN Position: Q3 2017 in Review

Cetera Investment Management sold out of Amgen (AMGN) in Q3 2017, closing a stake of 2,172 shares — an estimated $373K sold.

Cetera Investment Management first reported a position in AMGN in Q4 2015 and held it in 7 quarters. The position peaked at $1.14M in Q4 2015. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • Cetera Investment Management reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
  • Cetera Investment Management sold 2,172 Amgen shares in Q3 2017, an estimated $373K.
  • Cetera Investment Management first reported a position in Amgen in Q4 2015 and held it in 7 quarters.
  • Cetera Investment Management's Amgen position peaked at $1.14M in Q4 2015.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Cetera Investment Management's 13F filing for Q3 2017.